Therapeutic Asset Ratings
6,308 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Entinostat
Head And Neck Cancer
National Cancer Institute (NCI)
P1/2
CCC
(48)
Entinostat
Oropharyngeal Carcinoma
National Cancer Institute (NCI)
P1/2
CCC
(48)
Enzalutamide
Esophageal Cancer
Cancer Research UK
P1/2
CCC
(48)
Enzalutamide
Pancreatic Neoplasm
Nuvation Bio Inc.
P1/2
CCC
(48)
Enzomenib
Acute Lymphoblastic Leukemia
Sumitomo Pharma America, Inc.
P1/2
CCC
(48)
Epcoritamab
Aggressive B-Cell Non-Hodgkin Lymphoma
Genmab
P1/2
CCC
(48)
Epcoritamab
Indolent B-Cell Non-Hodgkin Lymphoma
Genmab
P1/2
CCC
(48)
Epinephrine
Oropharyngeal Carcinoma
National Cancer Institute (NCI)
P1/2
CCC
(48)
Epinephrine
Reproductive System Cancer
National Cancer Institute (NCI)
P1/2
CCC
(48)
Epsametostat
Epithelioid Sarcoma
Haihe Biopharma Co., Ltd.
P1/2
CCC
(48)
Epsametostat
Follicular Lymphoma
Haihe Biopharma Co., Ltd.
P1/2
CCC
(48)
Epstein-Barr Virus Specific T-Lymphocytes
Adenoviridae Infectious Disease
Jessie L. Alexander
P1/2
CCC
(48)
Epstein-Barr Virus Specific T-Lymphocytes
Cytomegalovirus Infection
Jessie L. Alexander
P1/2
CCC
(48)
Epstein-Barr Virus Specific T-Lymphocytes
Epstein-Barr Virus Infection
Jessie L. Alexander
P1/2
CCC
(48)
Eras-007
Pancreatic Ductal Adenocarcinoma
Erasca, Inc.
P1/2
CCC
(48)
ERIBULIN/FARLETUZUMAB ANTIBODY DRUG CONJUGATE
Neoplasm
Eisai Inc.
P1/2
CCC
(48)
ERIBULIN MONOMETHANESULFONATE
Urothelial Carcinoma
National Cancer Institute (NCI)
P1/2
CCC
(48)
ERIBULIN MONOMETHANESULFONATE
Inflammatory Breast Carcinoma
M.D. Anderson Cancer Center
P1/2
CCC
(48)
Esomeprazole
Metabolic Dysfunction-Associated Steatohepatitis
Sadat City University
P1/2
CCC
(48)
et140203 t cells
Liver Cancer
Eureka Therapeutics Inc.
P1/2
CCC
(48)
ETOPOSIDE
EZB-MYC+ Diffuse Large B-Cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University
P1/2
CCC
(48)
ex103
B-Cell Non-Hodgkin Lymphoma
Guangzhou Excelmab Inc.
P1/2
CCC
(48)
FLAVONE, 3,3',4',5,7-PENTAHYDROXY-
Metabolic Dysfunction-Associated Steatotic Liver Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
P1/2
CCC
(48)
Fludarabine
Urinary Bladder Carcinoma
Beijing Biotech
P1/2
CCC
(48)
Fludarabine
Castration-Resistant Prostate Carcinoma
Beijing Biotech
P1/2
CCC
(48)
Showing 1176 to 1200 of 6,308 assets
Previous
Page 48 of 253
Next